SCHEMBL463218

SCHEMBL463218

CC(C)(C)OC(=O)NC1CN(Cc2ccccc2)CCC1c1cc(F)ccc1F

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 7/20 0.48
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
ATM Q13315 1/20 0.46
DPP4 P27487 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
LMNA P02545 1/20 0.45
TP53 P04637 1/20 0.45
CCR3 P51677 1/20 0.44
DRD2 P14416 2/20 0.44
DRD4 P21917 2/20 0.44
NPY5R Q15761 3/20 0.44
CHRM4 P08173 1/20 0.43
BCHE P06276 1/20 0.43
ACHE P22303 1/20 0.43
BACE1 P56817 1/20 0.43
SLC6A12 P48065 1/20 0.43
TMEM97 Q5BJF2 1/20 0.43
MCHR1 Q99705 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL121387 1.00 SIGMAR1 (0.48) SIGMAR1KMT2AMEN1ATMDPP4
SCHEMBL147671 0.93 KMT2A (0.48) SIGMAR1KMT2AMEN1ATMDPP4
SCHEMBL147670 0.93 KMT2A (0.48) SIGMAR1KMT2AMEN1ATMDPP4
SCHEMBL147672 0.93 KMT2A (0.48) SIGMAR1KMT2AMEN1ATMDPP4
SCHEMBL1726613 0.92 KMT2A (0.48) SIGMAR1KMT2AMEN1L3MBTL1DRD2
SCHEMBL121388 0.92 KMT2A (0.48) SIGMAR1KMT2AMEN1L3MBTL1DRD2
SCHEMBL143625 0.85 MC1R (0.49) SIGMAR1KMT2AMEN1ATML3MBTL1
SCHEMBL143627 0.85 MC1R (0.49) SIGMAR1KMT2AMEN1ATML3MBTL1
SCHEMBL143626 0.85 MC1R (0.49) SIGMAR1KMT2AMEN1ATML3MBTL1
SCHEMBL19985856 0.84 L3MBTL1 (0.45) SIGMAR1KMT2AL3MBTL1TP53DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2406256-A1 COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS Prosidion Limited (GB) 2012-01-18 EP disclosed
WO-2011147951-A1 CYCLOAMINO DERIVATIVES AS GPR119 ANTAGONISTS PROSIDION LIMITED (GB) 2011-12-01 WO disclosed
WO-2010103335-A1 COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2010-09-16 WO disclosed